Filter Results :

Your search for antibod returned 150 reports

Sort by


Antinuclear Antibody Test Market by Product (Reagents & Assay Kits, Systems, Software, Services), Technique (Immunofluorescence, Elisa, Multiplex), Disease (Rheumatoid Arthritis, SLE), End User (Clinical Labs, Hospitals) - Forecast to 2021

21 Sep 2016  |  Published by:  MarketsandMarkets
The global antinuclear antibody (ANA) testing market is expected to reach USD 1,476.1 million by 2021 from USD 823.5 million in 2016, at a CAGR of 12.4%. The global ANA testing market is segmented based on products, diseases, techniques, end users, and regions. The assay kits & reagents segment ...

$ 5,650.00

Read More

Cancer Immunotherapy Market by Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators), Application (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck), End User (Hospital and Clinics) - Global Forecast to 2021

15 Sep 2016  |  Published by:  MarketsandMarkets
The global cancer immunotherapy market is expected to reach USD 119.39 billion by 2021 from USD 61.97 billion in 2016, at a CAGR of 14.0% from 2016 to 2021. Factors such as increasing incidence of cancer, rising healthcare expenditure, and increased access to medical insurance in developed countries...

$ 5,650.00

Read More

Global Breast Cancer Monoclonal Antibodies Market 2016-2020

06 Sep 2016  |  Published by:  Technavio-Infiniti Research
About Breast Cancer mAbsBreast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled ...

$ 2,500.00

Read More

Global Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

01 Sep 2016  |  Published by:  CurrentPartnering
The Global Monoclonal antibody Partnering Terms and Agreements 2010 to 2016: Deal trends, players, financials and forecasts report provides a detailed understanding and analysis of how and why companies enter monoclonal antibody partnering deals. The majority of deals are development stage whe...

$ 2,995.00

Read More

Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

01 Sep 2016  |  Published by:  CurrentPartnering
The Global Cancer Monoclonal Antibody Partnering 2010-2016: Deal trends, players, financials and forecasts report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies. -Trends in cancer...

$ 1,995.00

Read More

Antibody Production Market by Process (Upstream Processing, Downstream Processing, and Filtration), End-User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Research Institutes) - Global Forecast to 2021

18 Aug 2016  |  Published by:  MarketsandMarkets
The antibody production market is projected to reach USD 13.28 billion by 2021 from USD 7.45 billion in 2016, at a CAGR of 12.3% during the forecast period of 2016 to 2021. The antibody production market comprises products required during the different stages of bioprocessing of antibodies, su...

$ 5,650.00

Read More

United States Monoclone Antibody Market Report 2021

16 Aug 2016  |  Published by:  QYResearch
This report studies sales (consumption) of Monoclone Antibody in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering AbbVie Amgen Bristol-Myers Squibb F. Hoffmann-La Roche Johnson & Johnson Merck Bayer HealthCare Eli Lilly ...

$ 3,800.00

Read More

United States Monoclonal Antibody Market Report 2021

10 Aug 2016  |  Published by:  QYResearch
This report studies sales (consumption) of Monoclonal Antibody in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering Abbott Affymetrix Beckman Coulter/Danaher Becton Dickinson bioMerieux Bio-Rad Cepheid Diamedix/Erba DiaSorin ...

$ 3,800.00

Read More

Anti GM-CSF Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti GM-CSF Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti GM-CSF Antibody. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre...

$ 1,250.00

Read More

Anti-CD105 Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD105 Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD105 Antibody. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-c...

$ 1,250.00

Read More

Anti-CD152 Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD152 Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD152 Antibody. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-c...

$ 1,250.00

Read More

Anti-CD19 Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD19 Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD19 Antibody. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-cli...

$ 1,250.00

Read More

Anti-CD22 Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD22 Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD22 Antibody. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-cli...

$ 1,250.00

Read More

Anti-CD25 Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD25 Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD25 Antibody. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-cli...

$ 1,250.00

Read More

Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anti-CD274 (PD-L1) Antibody-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD274 (PD-L1) Antibody. The DelveInsights Report covers the product profiles in various stages of development including ...

$ 1,250.00

Read More
Total 150 records.